Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Abroad (travel likely)RecruitingPHASE3

Conditions

Mixed Dyslipidemia · Hypercholesterolaemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

FutureMeds North Tees, Stockton-on-Tees, United Kingdom

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

Primary Hypercholesterolaemia and Mixed Dyslipidemia

Abroad (travel likely)RecruitingPHASE3

Beijing, China

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Primary Hypercholesterolemiia · Mixed Dyslipidemia

Abroad (travel likely)Recruiting

Braunau am Inn, Austria · Feldkirch, Austria

A Study to Evaluate the Efficacy and Safety of AD-218

Mixed Dyslipidemia

Abroad (travel likely)RecruitingPHASE3

Daegu, South Korea

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Abroad (travel likely)RecruitingPHASE3

Beijing, China